Charles River Laboratories Inte Revenue 2008–2025
Charles River Laboratories Inte reported $4.02B of revenue for fiscal 2025. That was 0.9% lower than fiscal 2024. Compared with fiscal 2020, the change was +37.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $4.02B | -0.9% |
| FY 2024 | $4.05B | -1.9% |
| FY 2023 | $4.13B | +3.9% |
| FY 2022 | $3.98B | +12.3% |
| FY 2021 | $3.54B | +21.1% |
| FY 2020 | $2.92B | +11.5% |
| FY 2019 | $2.62B | +15.7% |
| FY 2018 | $2.27B | +22.0% |
| FY 2017 | $1.86B | +10.5% |
| FY 2016 | $1.68B | +23.3% |
| FY 2015 | $1.36B | +5.1% |
| FY 2014 | $1.30B | +11.3% |
| FY 2013 | $1.17B | +3.2% |
| FY 2012 | $1.13B | -1.1% |
| FY 2011 | $1.14B | +0.8% |
| FY 2010 | $1.13B | -3.3% |
| FY 2009 | $1.17B | -9.5% |
| FY 2008 | $1.30B | — |
Source: Charles River Laboratories Inte SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open CRL 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Charles River Laboratories Inte reported $4.02B of revenue for fiscal 2025. That was 0.9% lower than fiscal 2024. Compared with fiscal 2020, the change was +37.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Charles River Laboratories Inte
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCharles River Laboratories Inte — frequently asked questions
What is Charles River Laboratories Inte's revenue?
Charles River Laboratories Inte (CRL) reported revenue of $4.02B for fiscal year 2025, per its SEC filings.
How has Charles River Laboratories Inte's revenue changed over time?
Between fiscal 2008 and 2025, CRL's revenue grew at roughly 6.9% per year (compound annual rate), from $1.30B to $4.02B.
Where does this data come from?
Figures are computed from Charles River Laboratories Inte's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.